We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.92%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$223B
AUM Growth
+$132B
Cap. Flow
+$128B
Cap. Flow %
57.4%
Top 10 Hldgs %
41.38%
Holding
5,646
New
798
Increased
2,634
Reduced
1,094
Closed
385

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.5B
2
AAPL icon
Apple
AAPL
+$1.68B
3
TSLA icon
Tesla
TSLA
+$951M
4
JNJ icon
Johnson & Johnson
JNJ
+$750M
5
UNH icon
UnitedHealth
UNH
+$703M

Sector Composition

Rank Sector Weight
1 Technology 12.48%
2 Healthcare 7.36%
3 Financials 6.5%
4 Consumer Discretionary 5.35%
5 Industrials 3.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOCO
4476
DELISTED
GoHealth
GOCO
$38.1K ﹤0.01%
3,646
-13
-0.4% -$115
BCEL
4477
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$38K ﹤0.01%
47,487
-1,441
-3% -$1.83K
STTK icon
4478
Shattuck Labs
STTK
$675M
$37.9K ﹤0.01%
16,471
THRN
4479
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$37.3K ﹤0.01%
10,284
+3,109
+43% +$13.8K
MAGN
4480
Magnera Corp
MAGN
$472M
$37.2K ﹤0.01%
1,031
-776
-43% -$31.7K
SWIM icon
4481
Latham Group
SWIM
$629M
$37.2K ﹤0.01%
11,563
-30,830
-73% -$111K
INNV icon
4482
InnovAge Holding
INNV
$1.54B
$36.9K ﹤0.01%
5,137
+4,326
+533% +$27.8K
ARGX icon
4483
argenx
ARGX
$53.4B
$36.7K ﹤0.01%
97
HYZN
4484
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$36.5K ﹤0.01%
472
+398
+538% +$34K
YSG
4485
Yatsen Holding
YSG
$322M
$36.5K ﹤0.01%
5,000
-46,000
-90% -$277K
EVLO
4486
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$36.5K ﹤0.01%
1,132
+982
+655% +$38.9K
CURO
4487
DELISTED
CURO Group Holdings Corp.
CURO
$36.4K ﹤0.01%
10,240
+4,969
+94% +$18.9K
DRIV icon
4488
Global X Autonomous & Electric Vehicles ETF
DRIV
$377M
$36.3K ﹤0.01%
1,828
GHSI
4489
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$36.3K ﹤0.01%
5,000
LEE icon
4490
Lee Enterprises
LEE
$172M
$36K ﹤0.01%
+1,942
New +$35.2K
CUK
4491
DELISTED
Carnival PLC
CUK
$36K ﹤0.01%
5,000
HERA
4492
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
$35.9K ﹤0.01%
3,549
SNPO
4493
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
$35.8K ﹤0.01%
4,836
+4,072
+533% +$37.6K
PBFS icon
4494
Pioneer Bancorp
PBFS
$432M
$35.5K ﹤0.01%
3,116
+2,624
+533% +$28.6K
MKFG
4495
DELISTED
Markforged Holding Corporation
MKFG
$35.4K ﹤0.01%
3,055
+2,588
+554% +$39.4K
GHL
4496
DELISTED
Greenhill & Co., Inc.
GHL
$35.4K ﹤0.01%
3,456
+2,010
+139% +$17.4K
EEX
4497
DELISTED
Emerald Holding
EEX
$35.4K ﹤0.01%
9,996
+9,493
+1,887% +$34.1K
AEVA
4498
Aeva Technologies
AEVA
$1.2B
$35.4K ﹤0.01%
5,203
+4,381
+533% +$38.4K
IPAY icon
4499
Amplify Mobile Payments ETF
IPAY
$170M
$35.3K ﹤0.01%
900
CTV
4500
DELISTED
Innovid Corp.
CTV
$35.1K ﹤0.01%
20,536
+17,293
+533% +$46.8K

Similar funds

Barclays's Q4 2022 Portfolio in Review

As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.

  • Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
  • Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
  • Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
  • Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
  • Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
  • Barclays opened 798 new positions and closed 385 in Q4 2022.
  • Barclays's portfolio value rose 144% quarter-over-quarter to $223B.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.